Literature DB >> 9707188

Mortality and morbidity of surgery for unruptured intracranial aneurysms: a meta-analysis.

T W Raaymakers1, G J Rinkel, M Limburg, A Algra.   

Abstract

BACKGROUND AND
PURPOSE: Greater availability and improvement of neuroradiological techniques have resulted in more frequent detection of unruptured aneurysms. Because prognosis of subarachnoid hemorrhage is still poor, preventive surgery is increasingly considered as a therapeutic option. Elective surgery requires reliable data on its risks. Therefore, we performed a meta-analysis on the mortality and morbidity of surgery for unruptured intracranial aneurysms.
METHODS: Through Medline and additional searches by hand, we retrieved studies on clipping of unruptured (additional, symptomatic, or incidental) aneurysms published from 1966 through June 1996. Two authors independently extracted data. We used weighted linear regression for data analysis.
RESULTS: We included 61 studies that involved 2460 patients (57% female; mean age, 50 years) and at least 2568 unruptured aneurysms (27% >25 mm, 30% located in the posterior circulation). Mortality was 2.6% (95% confidence interval [CI], 2.0% to 3.3%). Permanent morbidity occurred in 10.9% (95% CI, 9.6% to 12.2%) of patients. Postoperative mortality was significantly lower in more recent years for nongiant aneurysms and aneurysms with an anterior location; the last 2 characteristics were also associated with a significantly lower morbidity.
CONCLUSIONS: In studies published between 1966 and 1996 on clipping of unruptured aneurysms, mortality was 2.6% and morbidity was 10.9%. In calculating the pros and cons of preventive surgery, these proportions should be taken into account.

Entities:  

Mesh:

Year:  1998        PMID: 9707188     DOI: 10.1161/01.str.29.8.1531

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  81 in total

1.  Screening for familial intracranial aneurysms.

Authors:  P J Kirkpatrick; R S McConnell
Journal:  BMJ       Date:  1999-12-11

2.  Subarachnoid haemorrhage in patients > or = 75 years: clinical course, treatment and outcome.

Authors:  D J Nieuwkamp; G J E Rinkel; R Silva; P Greebe; D A Schokking; J M Ferro
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04-25       Impact factor: 10.154

3.  Editorial: grading and decision-making in (aneurysmal) subarachnoid haemorrhage.

Authors:  J J Mooij
Journal:  Interv Neuroradiol       Date:  2002-01-10       Impact factor: 1.610

4.  HydroCoil as an adjuvant to bare platinum coil treatment of 100 cerebral aneurysms.

Authors:  Noel F Fanning; Zsolt Berentei; Paul R Brennan; John Thornton
Journal:  Neuroradiology       Date:  2006-11-22       Impact factor: 2.804

Review 5.  Ruptured intracranial aneurysms in the elderly: epidemiology, diagnosis, and management.

Authors:  Jacques Sedat; Mustapha Dib; David Rasendrarijao; Denys Fontaine; Michel Lonjon; Philippe Paquis
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

6.  Procedural morbidity and mortality of elective coil treatment of unruptured intracranial aneurysms.

Authors:  W J van Rooij; M Sluzewski
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

Review 7.  Modern cross-sectional imaging in the diagnosis and follow-up of intracranial aneurysms.

Authors:  Karsten Papke; Friedhelm Brassel
Journal:  Eur Radiol       Date:  2006-01-14       Impact factor: 5.315

8.  Benefits of surgical treatment for unruptured intracranial aneurysms in elderly patients.

Authors:  E-Wook Jang; Jin-Young Jung; Chang-Ki Hong; Jin-Yang Joo
Journal:  J Korean Neurosurg Soc       Date:  2011-01-31

9.  Translational research using a mouse model of intracranial aneurysm.

Authors:  Kosuke Wada; Hiroshi Makino; Kenji Shimada; Fumiaki Shikata; Atsushi Kuwabara; Tomoki Hashimoto
Journal:  Transl Stroke Res       Date:  2013-11-06       Impact factor: 6.829

10.  Resolution of mass effect and compression symptoms following endoluminal flow diversion for the treatment of intracranial aneurysms.

Authors:  I Szikora; M Marosfoi; B Salomváry; Z Berentei; I Gubucz
Journal:  AJNR Am J Neuroradiol       Date:  2013-03-14       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.